| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 27814 | 2017 |
| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3226 | 2013 |
| † Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology … L Ryden, E Standl, M Bartnik, GV Berghe, J Betteridge, MJ De Boer, ... European heart journal supplements 9 (suppl_C), C3-C74, 2007 | 2251 | 2007 |
| Adipokines and insulin resistance K Rabe, M Lehrke, KG Parhofer, UC Broedl Molecular medicine 14, 741-751, 2008 | 1278 | 2008 |
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 1197 | 2014 |
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 995 | 2015 |
| Defining high-fat-diet rat models: metabolic and molecular effects of different fat types R Buettner, KG Parhofer, M Woenckhaus, CE Wrede, LA Kunz-Schughart, ... Journal of molecular endocrinology 36 (3), 485-501, 2006 | 962 | 2006 |
| Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement F Kronenberg, S Mora, ESG Stroes, BA Ference, BJ Arsenault, L Berglund, ... European heart journal 43 (39), 3925-3946, 2022 | 777 | 2022 |
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 718 | 2014 |
| Diabetic dyslipidemia L Wu, KG Parhofer Metabolism 63 (12), 1469-1479, 2014 | 636 | 2014 |
| Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014 | 604 | 2014 |
| Clinical review on triglycerides U Laufs, KG Parhofer, HN Ginsberg, RA Hegele European heart journal 41 (1), 99-109c, 2020 | 541 | 2020 |
| Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia KG Parhofer Diabetes & metabolism journal 39 (5), 353, 2015 | 496 | 2015 |
| Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis M Lehrke, A Becker, M Greif, R Stark, RP Laubender, F von Ziegler, ... European journal of endocrinology 161 (2), 339-344, 2009 | 472 | 2009 |
| Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events BR Jaeger, Y Richter, D Nagel, F Heigl, A Vogt, E Roeseler, K Parhofer, ... Nature Reviews Cardiology 6 (3), 229-239, 2009 | 365 | 2009 |
| Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis M Greif, A Becker, F von Ziegler, C Lebherz, M Lehrke, UC Broedl, J Tittus, ... Arteriosclerosis, thrombosis, and vascular biology 29 (5), 781-786, 2009 | 348 | 2009 |
| HDL cholesterol: reappraisal of its clinical relevance W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, ... Clinical Research in Cardiology 106, 663-675, 2017 | 316 | 2017 |
| Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study P de Pablos‐Velasco, KG Parhofer, C Bradley, E Eschwège, ... Clinical endocrinology 80 (1), 47-56, 2014 | 281 | 2014 |
| Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved … SD Anker, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, ... European journal of heart failure 21 (10), 1279-1287, 2019 | 254 | 2019 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 249 | 2021 |
